Sweden reports drop in skin cancer rates for under 50s

The risk of skin cancer, malignant melanoma, now appears to be decreasing in Sweden – at least in those under 50, according to a new study.

Actimed plans trials to treat muscle wasting syndrome in cancer patients

Actimed plans to start two Phase IIb/III trials of its lead candidate in H1 2024. Credit: Shutterstock / Casa nayafana. UK-based Actimed Therapeutics is planning

July 13, 2023

Opioids Tied to Higher Dementia Risk, but Only After a Point

Cumulative high opioid use was tied to increased dementia risk in adults 60 and older. At or below a threshold of 90 total standardized doses,

November 20, 2024

Study reveals Pfizer bivalent COVID-19 booster safer for seniors against stroke risk compared to other vaccines

The comparative hazard of ischemic stroke (IS) in recipients of booster shots.

November 27, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.